We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

InvestoGain Australia

Celebrating 20 Years in Business

Thank you for being part of our development since September 2001. With your ongoing support we look forward to many exciting developments ahead.


Any AUS or NZ company


Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z



Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names


Shareholder links

Our website ranking of ICS: rating 3
(3 out of 5)



Boardroom Pty Ltd, Level 12, 225 George Street, Sydney NSW 2000

Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000ICS4
Address: Suite 3.03 20 Bond Street Sydney NSW 2000
Tel:  0419 263 514 Fax: 02 9251 2001

Date first listed: 23/12/1999
Company Secretary: Mr Gregory James Quirk
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: Health technology company, whose core business is the ownership and operation of Transactional Health Exchange Linking Multiple Applications (THELMA), as well as the provision of services to the health industry within Australia - THELMA is designed to rep

News & Events

Expand this box to read and print

The company lodges its Appendix 4E and Annual Report to shareholders.


The draft ruling provided by the ATO has now been finalised.


The company releases a notice of Dividend/Distribution - ICS.


The company releases a notice of Return of Capital - ICS.


The company releases the results of its meeting.


The company releases its Chairman's Address to Shareholders.


Due to recently announced COVID-19 restrictions, its Extraordinary General Meeting that was scheduled to be held at Hall Chadwick, Level 40, 2 Park Street, Sydney NSW 2000 on Wednesday, 7 th July 2021 will now be held as a Virtual Meeting at the same time, Wednesday, 7 th July 2021 at 10:00am (AEST).


The securities of ICS Global Limited will be suspended from quotation at the close of business today, 21 June 2021, being six months from the date of the agreement to dispose ICS's main undertaking in accordance with Listing Rule 17.3. ASX is also likely to exercise its discretions under Listing Rule 11.1.2 to require any new proposed acquisitions to be conditional on approval by ICS's ordinary security holders and under Listing Rule 11.1.3 to require ICS to re-comply with Chapters 1 and 2 of the Listing Rules before trading is reinstated.


we understand that on or about this date the company consolidated its shares 1 for 20


the suspension of trading in the securities of ICSGlobal Limited will be lifted immediately, following receipt of an announcement in respect of its fundraising activities


the securities of ICSGlobal Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to a possible fundraising

OFX Transferring Money Internationally to Free


Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.


Company Updates

Post your comments here

Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...



    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    27/06/2017Kevin Barry10,000$1.023$10,227
    19/06/2017Viktor Shkolnik3,366$1.010$3,400
    15/11/2016Gregory Quirk7,100$1.414$10,042
    16/09/2016Robert Canning-Ure-140,000$1.583$221,640
    16/03/2016Robert Canning-Ure-10,000$1.556$15,563

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    Kevin BarryChairman22/07/2010
    Viktor ShkolnikDirector29/07/2010
    Gregory QuirkDirector30/04/2010
    Robert Canning-UreDirector04/08/2010

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    Timothy MurrayNon Exec Director22/04/199611/09/2011
    Ross BunyonNon Exec Chairman30/01/200701/08/2010
    Geoff LambertNon Exec Director01/07/199925/07/2010
    Dean PritchardChairman19/06/199910/06/2007

    Date of first appointment, title may have changed.